Radiotherapy Center Cluj S.R.L.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Gastric and oesophageal cancer1 trial
• Lung cancer1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed3 trials

Lead sponsor

• Abbvie Deutschland GmbH & Co. KG1 trial
• Bristol Myers Squibb International Corporation1 trial
• Bristol-Myers Squibb1 trial

Closed trials

• Completed

  A Study to Assess Disease Activity of Intravenously (IV) Infused Telisotuzumab Vedotin in Adult Participants with Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

  NCT05513703· Phase 2· Abbvie Deutschland GmbH & Co. KG· Source

• Completed

  A study of nivolumab or placebo in patients following removal of their esophageal or gastroesophageal junction cancer.

  NCT02743494· Phase 3· Bristol Myers Squibb International Corporation· Source

• Completed

  An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer

  NCT02632409· Phase 3· Bristol-Myers Squibb· Source